- Home
- NRC
as 11-21-2024 12:38pm EST
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | LINCOLN |
| Market Cap: | 426.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 80.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.12 | EPS Growth: | -3.16 |
| 52 Week Low/High: | $17.62 - $42.20 | Next Earning Date: | 10-25-2024 |
| Revenue: | $144,155,000 | Revenue Growth: | -3.07% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest National Research Corporation (Delaware) News
NRC Breaking Stock News: Dive into NRC Ticker-Specific Updates for Smart Investing
Business Wire
a day ago
Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health
Business Wire
9 days ago
Cooper University Health Care Selects NRC Health as New Patient Experience Partner
Simply Wall St.
21 days ago
National Research (NASDAQ:NRC) Has Announced A Dividend Of $0.12
Simply Wall St.
25 days ago
Why National Research Corporation (NASDAQ:NRC) Looks Like A Quality Company
Business Wire
a month ago
National Research Corporation Announces Third Quarter Results
Simply Wall St.
2 months ago
National Research (NASDAQ:NRC) investors are sitting on a loss of 61% if they invested five years ago
Business Wire
3 months ago
AI meets empathy: NRC Health launches first AI-enabled solutions to elevate healthcare experience
Simply Wall St.
3 months ago
National Research Second Quarter 2024 Earnings: EPS: US$0.26 (vs US$0.30 in 2Q 2023)
Compare NRC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NRC National Research Corporation (Delaware) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.